In summary, our results present two new NAT2 variants and showed a statistically significant association of the NAT2*5/*5 genotype carriers with the development of anti-TB DIH, pointing out the relevance of discriminating the slow acetylator genotypes in homozygotes and compound heterozygotes. The gene discussed is NAT2; the disease is tuberculosis.